187 related articles for article (PubMed ID: 28636736)
1. The protective effect of intratympanic dexamethasone on streptomycin ototoxicity in rats.
Gül A; Şengül E; Yılmaz B; Özkurt FE; Akdağ M; Keleş A; Topçu İ
Ear Nose Throat J; 2017 Jun; 96(6):E12-E17. PubMed ID: 28636736
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the protective efficacy between intratympanic dexamethasone and resveratrol treatments against cisplatin-induced ototoxicity: an experimental study.
Simsek G; Taş BM; Muluk NB; Azman M; Kılıç R
Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3287-3293. PubMed ID: 31531774
[TBL] [Abstract][Full Text] [Related]
3. The effect of corticosteroid against streptomycin ototoxicity.
Kinis V; Ozbay M; Bakir S; Sengul E; Yorgancilar E; Keles A; Alabalik U; Meric F
J Craniofac Surg; 2013; 24(5):1726-30. PubMed ID: 24036765
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the cochlear effects of intratympanic steroids administered following acoustic trauma.
Ozdogan F; Ensari S; Cakir O; Ozcan KM; Koseoglu S; Ozdas T; Gurgen SG; Dere H
Laryngoscope; 2012 Apr; 122(4):877-82. PubMed ID: 22374513
[TBL] [Abstract][Full Text] [Related]
5. The protective effect of intratympanic dexamethasone on cisplatin-induced ototoxicity in guinea pigs.
Daldal A; Odabasi O; Serbetcioglu B
Otolaryngol Head Neck Surg; 2007 Nov; 137(5):747-52. PubMed ID: 17967639
[TBL] [Abstract][Full Text] [Related]
6. The protective role of caffeic acid phenethyl ester against streptomycin ototoxicity.
Bakır S; Özbay M; Gün R; Yorgancılar E; Kınış V; Keleş A; Abakay A; Gökalp O; Topçu İ
Am J Otolaryngol; 2013; 34(1):16-21. PubMed ID: 22964505
[TBL] [Abstract][Full Text] [Related]
7. Effects of ozone (O
Koçak HE; Taşkın Ü; Aydın S; Oktay MF; Altınay S; Çelik DS; Yücebaş K; Altaş B
Eur Arch Otorhinolaryngol; 2016 Dec; 273(12):4153-4159. PubMed ID: 27221387
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of 2 Different Intratympanic Steroid Regimen on Prevention of Cisplatin Ototoxicity: An Experimental Study.
Taş BM; Şimşek G; Azman M; Kılıç R
Ear Nose Throat J; 2021 Jul; 100(6):417-422. PubMed ID: 31569969
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the protective effects of hesperetin against cisplatin-induced ototoxicity in a rat animal model.
Kara M; Türkön H; Karaca T; Güçlü O; Uysal S; Türkyılmaz M; Demirtaş S; Dereköy FS
Int J Pediatr Otorhinolaryngol; 2016 Jun; 85():12-8. PubMed ID: 27240489
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the protective effects of intratympanic dexamethasone and methylprednisolone against cisplatin-induced ototoxicity.
Özel HE; Özdoğan F; Gürgen SG; Esen E; Genç S; Selçuk A
J Laryngol Otol; 2016 Mar; 130(3):225-34. PubMed ID: 26830667
[TBL] [Abstract][Full Text] [Related]
11. Effects of intratympanic dexamethasone on noise-induced hearing loss: An experimental study.
Gumrukcu SS; Topaloglu İ; Salturk Z; Tutar B; Atar Y; Berkiten G; Göker AE
Am J Otolaryngol; 2018; 39(1):71-73. PubMed ID: 29110919
[TBL] [Abstract][Full Text] [Related]
12. Levosimendan ameliorates cisplatin-induced ototoxicity: Rat model.
Gozeler MS; Ekinci Akdemir FN; Yildirim S; Sahin A; Eser G; Askin S
Int J Pediatr Otorhinolaryngol; 2019 Jul; 122():70-75. PubMed ID: 30978472
[TBL] [Abstract][Full Text] [Related]
13. Effect of intratympanic dexamethasone administration on cisplatin-induced ototoxicity in adult guinea pigs.
Shafik AG; Elkabarity RH; Thabet MT; Soliman NB; Kalleny NK
Auris Nasus Larynx; 2013 Feb; 40(1):51-60. PubMed ID: 22884636
[TBL] [Abstract][Full Text] [Related]
14. Cochlear and Vestibular Effects of Combined Intratympanic Gentamicin and Dexamethasone.
Güneri EA; Olgun Y; Aslıer M; Nuti D; Kırkım G; Mungan S; Kolatan E; Aktaş S; Trabalzini F; Ellidokuz H; Yılmaz O; Mandala M
J Int Adv Otol; 2017 Apr; 13(1):47-52. PubMed ID: 28084995
[TBL] [Abstract][Full Text] [Related]
15. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
[TBL] [Abstract][Full Text] [Related]
16. [Otoacoustic emissions measurements in children during the chemotherapy because of the acute lymphoblastic leukemia].
Lisowska G; Namysłowski G; Hajduk A; Polok A; Tomaszewska R; Misiołek M
Otolaryngol Pol; 2006; 60(3):415-20. PubMed ID: 16989457
[TBL] [Abstract][Full Text] [Related]
17. Effects of a dexamethasone-releasing implant on cochleae: A functional, morphological and pharmacokinetic study.
Liu Y; Jolly C; Braun S; Janssen T; Scherer E; Steinhoff J; Ebenhoch H; Lohner A; Stark T; Kiefer J
Hear Res; 2015 Sep; 327():89-101. PubMed ID: 25987502
[TBL] [Abstract][Full Text] [Related]
18. Ototoxicity screening of patients treated with streptomycin using distortion product otoacoustic emissions.
Md Daud MK; Mohamadl H; Haron A; Rahman NA
B-ENT; 2014; 10(1):53-8. PubMed ID: 24765829
[TBL] [Abstract][Full Text] [Related]
19. Protective role of misoprostol in prevention of gentamicin ototoxicity.
Dogan M; Polat H; Yasar M; Bayram A; Karatas D; Hira İ; Kale A; Senel F; Özcan İ
Int J Pediatr Otorhinolaryngol; 2017 May; 96():140-144. PubMed ID: 28390604
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of melatonin against gentamicin ototoxicity.
Ye LF; Tao ZZ; Hua QQ; Xiao BK; Zhou XH; Li J; Yuan YL
J Laryngol Otol; 2009 Jun; 123(6):598-602. PubMed ID: 18957160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
